The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Sheetal M KircherYu-Ning Wong

Abstract

Over the last decade, there has been increased development and use of oral anticancer medications, which sometimes leads to high cost sharing for patients. Drug parity laws require insurance plans to cover oral anticancer medications with the same cost sharing as intravenous/injected chemotherapy or have a capped limit on out-of-pocket costs. There are currently 36 enacted state laws (plus the District of Columbia) addressing drug parity, but no federal laws. In this policy perspective piece, we discuss the history, opportunities, and limitations of drug parity laws in oncology. We also discuss the implications of provisions of the Affordable Care Act and other proposed policy reforms on financing oral chemotherapy.

References

Jan 1, 1990·Cancer·A H LebovitsM R Messe
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TwelvesUNKNOWN Xeloda Colorectal Cancer Study Group
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter B Bach
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeHyman Muss
Apr 14, 2011·BMC Cancer·Sarah SchottMichael H Eichbaum
Sep 3, 2011·Journal of Oncology Practice·Sonya Blesser StreeterMichael Johnsrud
Feb 4, 2014·Journal of Social Work in Disability & Rehabilitation·Richard G FrankSherry A Glied
Jul 10, 2014·The New England Journal of Medicine·David H Howard
Jan 27, 2015·MAbs·Mark A SocinskiDolca Thomas
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lynn J Howie, Jeffrey M Peppercorn
May 20, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ya-Chen Tina ShihThomas J Smith

❮ Previous
Next ❯

Citations

Apr 18, 2016·Current Hematologic Malignancy Reports·Jeffrey BetcherNandita Khera
May 5, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ya-Chen Tina ShihFabrice Smieliauskas
May 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam J OlszewskiAmal N Trivedi
Feb 15, 2018·Journal of Oncology Practice·Adam J OlszewskiJustin P Huynh
Aug 17, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam J OlszewskiAmy J Davidoff
Aug 18, 2018·Oncology Nursing Forum·Victoria K MarshallRebecca H Lehto
Aug 24, 2018·Journal of Oncology Practice·Fumiko ChinoS Yousuf Zafar
Jan 17, 2019·Journal of Surgical Oncology·Robert LentzSheetal Kircher
Aug 5, 2017·Cancer Causes & Control : CCC·Amelie G Ramirez, Ian M Thompson
Dec 29, 2019·Journal of the National Cancer Institute·Stacie B DusetzinaNancy L Keating
Mar 28, 2017·Journal of Managed Care & Specialty Pharmacy·Leah L ZulligS Yousuf Zafar
Jul 10, 2018·Current Hematologic Malignancy Reports·Talal HilalJose F Leis
Feb 6, 2021·Social Science & Medicine·Yichen Shen, Haruko Noguchi
Dec 24, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Laurie E McLouthKathryn E Weaver
Aug 6, 2021·Cost Effectiveness and Resource Allocation : C/E·Faride Sadat JalaliSajad Delavari
May 21, 2019·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Hansoo KimDanny Liew

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses
The American Journal of Orthopedics
James P Tasto
© 2022 Meta ULC. All rights reserved